An Interprofessional Approach to Managing Multidrug-Resistant Bacterial Infections

Released On
February 26, 2021

Expires On
February 26, 2022

Media Type
Internet

Completion Time
90 minutes

Specialty
Acute Care, Hospitalist, Infectious Disease

Topic(s)
Pharmacology

Scroll to the Bottom of this Information to Begin this Course

Provided by the American Academy of CME, Inc.

This activity is supported in part by an independent education grant from Merck.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of infectious disease physicans and pharmacists.

Program Overview

This activity will help clinicians develop an interprofessioal approach to managing multidrug-resistant bacterial infections. The number of formally ID-trained pharmacists and physicians are limited across the country. This means that there is a growing role for general pharmacists and ID physicians to optimally manage their patients’ antibiotics in the hospital or outpatient settings as well as fulfill necessary expert roles in antibiotic stewardship programs. In order to do so, physicians and pharmacists will need education regarding the current state of drug-resistant infections and current/emerging antibiotic therapies.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  1. Describe the epidemiology and mechanisms of drug-resistance among Gram-negative (GNB) and Gram-positive (GPB) bacterial infections
  2. Analyze the pharmacology and antibacterial activity of current and emerging antibiotic therapies for multidrug-resistant (MDR) GNB and GPB infections
  3. Explain the clinical evidence and clinical utility of new antibiotic therapies for MDR GNB and MDR GPB infections
  4. Evaluate how the interprofessional team can work together to manage antibiotic therapies for MDR GNB and MDR GPB infections and their roles as antibiotic stewardship program members

Faculty

Pinki J. Bhatt, MD

Assistant Professor, Division of Infectious Diseases
Associate Program Director, Infectious Disease Fellowship Program
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Adjunct Assistant Professor, Rutgers Ernest Mario School of Pharmacy, New Brunswick, NJ

Pinki J. Bhatt is an Assistant Professor in the Division of Allergy/Immunology and Infectious Diseases at the Rutgers Robert Wood Johnson Medical School and an adjunct Assistant Professor at the Rutgers Ernest Mario School of Pharmacy in New Brunswick, NJ. She is also an Associate Program Director for the Infectious Diseases Fellowship Program for the Department of Medicine at Rutgers Robert Wood Johnson Medical School.

Navaneeth Narayanan, PharmD, MPH, BCIDP, BCPS

Clinical Associate Professor
Department of Pharmacy Practice and Administration
Rutgers University Ernest Mario School of Pharmacy, New Brunswick, NJ

Navaneeth (Nav) Narayanan is a Clinical Associate Professor in the Department of Pharmacy Practice and Administration at the Rutgers University Ernest Mario School of Pharmacy and jointly practices as an Infectious Diseases Clinical Pharmacist and Antimicrobial Stewardship Co-Director at Robert Wood Johnson University Hospital in New Brunswick, NJ. He is also an adjunct Assistant Professor in the Division of Infectious Diseases at Rutgers Robert Wood Johnson Medical School and an Adjunct Faculty/Medical Consultant for the Global Tuberculosis Institute at Rutgers New Jersey Medical School. He serves as an Advisor for the CLSI Antimicrobial Susceptibility Testing Subcommittee.

Joint Accreditation Statement

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 


Credit Designation

Physician

American Academy of CME, Inc designates this enduring material for 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Faculty

Pinki J. Bhatt, MD has the following disclosures to report:

  • No relevant financial relationships with any commercial interests.

Navaneeth Narayanan, PharmD, MPH, BCPS has the following disclosures to report:

  • Grant Recipient/Research Support: Astellas
  • Promotional Speaker’s Bureau: Astellas

Planning Committee

John JD Juchniewicz, MCIS, CHCP, Wendy Gloffke, PhD and Paul J. Miniter, MS

  • No relevant financial relationships with any commercial interests.

Content Reviewer

Philip Coco, PharmD

  • No relevant financial relationships with any commercial interests.

Instructions for Participation and Credit

There are no fees for participating and receiving CE credit for this enduring activity. To receive CME credit participants must:

  1. Read the CE information and faculty and planner disclosures.
  2. Participate in the online activity.
  3. Complete the post test (achieving a passing score of 70% or greater) and submit the evaluation form.

Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

American Academy of CME, Inc (Academy) requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. This activity will review off-label or investigational information.

Disclaimer

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy.

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For CE questions please contact: CEServices@academycme.org.